Novartis AG ADR buy StockNews.com
Start price
28.11.23
/
50%
€88.20
Target price
28.11.24
-
Performance (%)
13.95%
End price
29.11.24
€100.50
Summary
This prediction ended on 29.11.24 with a price of €100.50. The prediction had a final performance of 13.95%. StockNews_com has a follow-up prediction for Novartis AG ADR where he still thinks Novartis AG ADR is a Buy. A total of €3.45 was paid as dividends for this prediction. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | 2.954% | 2.954% | 29.787% |
| iShares Core DAX® | 1.822% | 3.926% | 23.507% |
| iShares Nasdaq 100 | 1.093% | -0.585% | 6.034% |
| iShares Nikkei 225® | 3.042% | 1.335% | 17.437% |
| iShares S&P 500 | 1.247% | 0.836% | 4.374% |
Comments by StockNews_com for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten